Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study.
Se Young ChoiMoon Soo HaByung Hoon ChiJin Wook KimIn Ho ChangTae-Hyoung KimSoon Chul MyungMyoungsuk KimKyung-Eun LeeYuwon KimHyun-Ki WooDae-Sung KyoungHasung KimPublished in: Journal of cancer research and clinical oncology (2022)
Neoadjuvant chemotherapy was associated with lower granulocyte colony-stimulating factor administration and better overall survival than adjuvant chemotherapy. Neoadjuvant chemotherapy should be considered for patients with bladder cancer who undergo radical cystectomy.